2024-11-12 - Analysis Report
## Teladoc Health Inc. (TDOC) Stock Analysis

**1.  Performance Comparison:**

Teladoc Health (TDOC) is a telemedicine company that provides virtual healthcare services. It has experienced significant underperformance compared to the S&P 500 (VOO) over the past years. 

| Year       | CAGR | MDD  | Alpha | Beta | Market Cap (B) | Cumulative Return (TDOC) | Cumulative Return (VOO) | Return Difference |
|------------|------|------|-------|------|---------------|--------------------------|-------------------------|--------------------|
| 2015-2017  | 83.4% | 54.5% | 53.2% | 1.3 | 6.00 |                          |                        |                  |
| 2016-2018  | 175.5% | 46.7% | 150.9% | 1.7 | 8.53 |                          |                        |                  |
| 2017-2019  | 407.4% | 46.7% | 364.3% | 1.8 | 14.41 |                          |                        |                  |
| 2018-2020  | 452.4% | 46.7% | 413.3% | 0.6 | 34.43 |                          |                        |                  |
| 2019-2021  | 90.6% | 55.8% | 0.8% | 0.5 | 15.81 |                          |                        |                  |
| 2020-2022  | -71.6% | 61.0% | -89.3% | 0.8 | 4.07 | 52.56%                    | 141.34%                | -88.78%            |
| 2021-2023  | -89.3% | 64.9% | -118.1% | 2.0 | 3.71 |                          |                        |                  |
| 2022-2024  | -90.3% | 45.9% | -115.5% | 1.9 | 1.64 |                          |                        |                  |

**Analysis:**

The cumulative return difference between TDOC and VOO shows that TDOC has lagged the S&P 500 by a significant margin, currently sitting -88.78% below the index. While TDOC's performance has been volatile, with periods of strong growth, the overall trend shows a significant decline in recent years. This suggests the company may be struggling to adapt to the changing market landscape. 

**2.  Recent Price Movement:**

* **Closing Price:** $9.23 (Last Market: $9.78)
* **5-Day Moving Average:** $9.24
* **20-Day Moving Average:** $9.16
* **60-Day Moving Average:** $8.44

**Analysis:**

The price of TDOC is currently trading slightly above its 5-day moving average and 20-day moving average, indicating a potential short-term uptrend. However, the price is still below its 60-day moving average, suggesting a long-term downtrend might be in place.

**3.  Technical Indicators:**

* **RSI:** 48.93
* **PPO:** 0.06
* **Delta_Previous_Relative_Divergence:** -0.6 (-)
* **Expected Return:** 0.0%

**Analysis:**

The RSI indicates that TDOC is currently in neutral territory, neither overbought nor oversold. The PPO is positive, suggesting a potential upward trend. However, the negative Delta_Previous_Relative_Divergence suggests a recent decline in relative strength. The Expected Return of 0.0% implies that the current market conditions do not suggest any significant outperformance potential against the S&P 500 over the long term.

**4.  Recent Earnings and Outlook:**

| Date       | EPS | Revenue |
|------------|------|---------|
| 2024-10-31 | -0.19 | 0.64 B$  |
| 2024-08-01 | -4.92 | 0.64 B$  |
| 2024-04-26 | -0.49 | 0.65 B$  |
| 2023-10-27 | -0.35 | 0.66 B$  |
| 2023-10-31 | -0.35 | 0.66 B$  |

**Analysis:**

Teladoc has consistently posted negative earnings in recent quarters, reflecting ongoing struggles in profitability. The company's revenue has remained relatively stable, indicating a lack of significant growth. The most recent earnings report was not available for review. 

**5.  Financial Information:**

**Revenue and Profitability:**

| Quarter     | Revenue   | Profit Margin |
|--------------|----------|---------------|
| 2024-09-30 | $0.64B  | 71.94%        |
| 2024-06-30 | $0.64B  | 70.73%        |
| 2024-03-31 | $0.65B  | 69.89%        |
| 2023-12-31 | $0.66B  | 70.72%        |
| 2023-09-30 | $0.66B  | 71.83%        |

**Capital and Profitability:**

| Quarter     | Equity    | ROE      |
|--------------|-----------|----------|
| 2024-09-30 | $1.51B  | -2.21%   |
| 2024-06-30 | $1.50B  | -55.77%  |
| 2024-03-31 | $2.29B  | -3.58%   |
| 2023-12-31 | $2.33B  | -1.24%   |
| 2023-09-30 | $2.29B  | -2.49%   |

**Analysis:**

Teladoc's profitability has remained consistent, although the company has faced challenges with return on equity (ROE) in recent quarters. The negative ROE suggests the company is not effectively using its equity to generate profits.

**6.  News and Recent Issues:**

* **Earnings News:** No recent earnings news was found within the last two days.
* **Recent Market Outlook:** The market outlook for TDOC remains uncertain. The company faces headwinds related to competition, regulatory changes, and the evolving healthcare landscape. 
* **Analyst Opinions:** Many analysts have a "Hold" or "Sell" rating on TDOC, reflecting concerns about its financial performance and future prospects.
* **Performance Highlights:** TDOC's recent performance has been underwhelming, and the company is facing significant challenges in regaining investor confidence.

**7.  Overall Analysis:**

TDOC has experienced significant underperformance compared to the S&P 500, with a negative cumulative return difference of -88.78%. While the recent price movement shows a potential short-term uptrend, the long-term trend remains bearish. The company is facing challenges in profitability and return on equity, with negative earnings and low ROE. The uncertain market outlook and negative analyst opinions contribute to the overall bearish sentiment surrounding the stock. The current conditions do not suggest any significant outperformance potential against the S&P 500 over the long term. 

**8.  Recommendations:**

Based on the analysis, TDOC appears to be a risky investment. The company's struggles in profitability and negative return on equity are significant concerns. The lack of a clear path to profitability and the uncertain market outlook for telemedicine contribute to the overall risk. Investors should exercise caution and carefully consider the risks before investing in TDOC. 
